订阅小程序
旧版功能

NY-ESO-1-specific T Cell Receptor-Engineered T Cells and Tranilast, a TRPV2 Antagonist Bivalent Treatment Enhances the Killing of Esophageal Cancer: a Dual-Targeted Cancer Therapeutic Route

Obed Boadi Amissah, Wenfang Chen,Jean de Dieu Habimana,Yirong Sun,Lihui Lin,Yujie Liu, Ling Wang,Zhaoming Liu,Omar Mukama,Rajesh Basnet, Hohua Liu, Junyi Li,Xuanyan Ding, Lingshuang Lv,Min Chen, Yalin Liang,Rongqi Huang,Zhiyuan Li

Cancer Cell International（2024）

引用 3|浏览27
关键词
Adoptive therapy,Cytotoxic T lymphocytes,Esophageal cancer (EC),NY-ESO-1 antigen,T cell receptor-engineered T cell (TCR-T),Tranilast
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要